Medscape Report Points to New Isotretinoin Data in Acne Care
Medscape's new report gathers fresh research insights on isotretinoin, the oral retinoid central to severe acne therapy. Dermologists should watch for practice implications.
Topic
Acne Vulgaris
Topic
Acne Vulgaris
Eucerin adds live-probiotic acne line, leans on microbiome pitch
Eucerin has launched a live-probiotic acne product framed as microbiome-friendly. Trade coverage names the active and positioning…
Denifanstat Sustains Acne Improvement Through 52 Weeks in Phase 3 Extension
Phase 3 extension data show denifanstat, an oral fatty acid synthase inhibitor, sustained acne improvement through 52 weeks — the…
Denifanstat Shows Deeper Acne Results Through 52 Weeks
Denifanstat, an investigational oral acne therapy, showed deeper results through 52 weeks of treatment in data presented at the 2…
Denifanstat Sustains Acne Lesion Reductions Through 52 Weeks
Denifanstat, an oral FASN inhibitor, sustained acne lesion reductions through 52 weeks in a Phase 3 open-label extension, per Der…
Digital Skincare Marketing Shapes Acne Self-Experimentation and Adherence
A Cureus psychodermatological review links digital skincare marketing to self-experimentation and poor adherence in acne vulgaris…